Paper17511683
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
Fisher RA and 11 others. Am J Transplant, 2007. Cited by 211 papers, by iCite.
Cite this record
ConductScience Library. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Papers, record 17511683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17511683
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Liver Transplantation | Major topic |
| Living Donors | Major topic |
| Postoperative Complications | Major topic |
| Tissue Donors | Major topic |
| Adult | |
| Aged | |
| Cadaver | |
| Cohort Studies | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Retrospective Studies | |
| Survival Analysis | |
| Time Factors | |
| Waiting Lists |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 DK062496 | NIDDK NIH HHS | United States | U01DK062496 | PubMed and NIH | NIH RePORTER |
| U01 DK062536 | NIDDK NIH HHS | United States | U01DK062536 | PubMed and NIH | NIH RePORTER |
| U01 DK062531 | NIDDK NIH HHS | United States | U01DK062531 | PubMed and NIH | NIH RePORTER |
| U01 DK062498 | NIDDK NIH HHS | United States | U01DK062498 | PubMed and NIH | NIH RePORTER |
| U01 DK062444 | NIDDK NIH HHS | United States | U01DK062444 | PubMed and NIH | NIH RePORTER |
| U01 DK062505 | NIDDK NIH HHS | United States | U01DK062505 | PubMed and NIH | NIH RePORTER |
| U01 DK062484 | NIDDK NIH HHS | United States | U01DK062484 | PubMed and NIH | NIH RePORTER |
| U01 DK062494 | NIDDK NIH HHS | United States | U01DK062494 | PubMed and NIH | NIH RePORTER |
| U01 DK062483 | NIDDK NIH HHS | United States | U01DK062483 | PubMed and NIH | NIH RePORTER |
| U01 DK062467 | NIDDK NIH HHS | United States | U01DK062467 | PubMed and NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00096733 | Adult-to-Adult Living Donor Liver Transplantation Study | Results | ClinicalTrials.gov | |
| NCT01619475 | Adult-to-Adult Living Donor Transplant Cohort Study | Background | ClinicalTrials.gov |
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16135918 | Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. | Ann Surg | 2005 | https://conductscience.org/library/papers/16135918 | PubMed |
| 2 | 15004774 | The role and limitation of living donor liver transplantation for hepatocellular carcinoma. | Liver Transpl | 2004 | https://conductscience.org/library/papers/15004774 | PubMed |
| 3 | 16315294 | A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. | Liver Transpl | 2005 | https://conductscience.org/library/papers/16315294 | PubMed |
| 4 | 12360427 | Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. | Liver Transpl | 2002 | https://conductscience.org/library/papers/12360427 | PubMed |
| 5 | 12200776 | The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? | Liver Transpl | 2002 | https://conductscience.org/library/papers/12200776 | PubMed |
| 6 | 15508095 | Living donor liver transplantation for hepatocellular carcinoma. | Gastroenterology | 2004 | https://conductscience.org/library/papers/15508095 | PubMed |
| 7 | 9416873 | United Network for Organ Sharing. | Circulation | 1997 | https://conductscience.org/library/papers/9416873 | PubMed |
| 8 | 12783395 | Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. | Liver Transpl | 2003 | https://conductscience.org/library/papers/12783395 | PubMed |
| 9 | 11343234 | Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. | Hepatology | 2001 | https://conductscience.org/library/papers/11343234 | PubMed |
| 10 | 16440361 | Deaths on the liver transplant waiting list: an analysis of competing risks. | Hepatology | 2006 | https://conductscience.org/library/papers/16440361 | PubMed |
| 11 | 11084076 | American Society of Transplant Surgeons' position paper on adult-to-adult living donor liver transplantation. | Liver Transpl | 2000 | https://conductscience.org/library/papers/11084076 | PubMed |
| 12 | 15344951 | Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. | Clin Transplant | 2004 | https://conductscience.org/library/papers/15344951 | PubMed |
| 14 | 15113360 | Improving liver allocation: MELD and PELD. | Am J Transplant | 2004 | https://conductscience.org/library/papers/15113360 | PubMed |
| 15 | 14745321 | Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. | Ann Surg | 2004 | https://conductscience.org/library/papers/14745321 | PubMed |
| 16 | 8594428 | Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8594428 | PubMed |
| 17 | 16489583 | Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. | Liver Transpl | 2006 | https://conductscience.org/library/papers/16489583 | PubMed |
| 18 | 15508093 | Liver transplantation for hepatocellular carcinoma. | Gastroenterology | 2004 | https://conductscience.org/library/papers/15508093 | PubMed |
| 19 | 15319716 | Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. | Ann Surg | 2004 | https://conductscience.org/library/papers/15319716 | PubMed |
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42122246 | Recurrence of Colorectal Cancer After Liver Transplant for Isolated Colorectal Liver Metastases: A Narrative Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122246 | PubMed |
| 40866831 | A serum TNFR2-based model effectively predicates preoperative microvascular invasion and stratifies the tumor recurrence risk in hepatocellular carcinoma. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/40866831 | PubMed |
| 40806987 | Liver Transplantation for Cancer-Current Challenges and Emerging Solutions. | J Clin Med | 2025 | https://conductscience.org/library/papers/40806987 | PubMed |
| 40636141 | Liver transplantation for malignant liver tumors. | ILIVER | 2022 | https://conductscience.org/library/papers/40636141 | PubMed |
| 40364079 | Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma and HCV Patients: An Initial Umbrella Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/40364079 | PubMed |
| 40361345 | Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40361345 | PubMed |
| 40206277 | Hepatocellular Carcinoma and the Role of Liver Transplantation: An Update and Review. | J Clin Transl Hepatol | 2025 | https://conductscience.org/library/papers/40206277 | PubMed |
| 39376229 | Beyond graft function impairment after liver transplantation: the prolonged cold ischemia time impact on recurrence of hepatocellular carcinoma after liver transplantation-a single-center retrospective study. | PeerJ | 2024 | https://conductscience.org/library/papers/39376229 | PubMed |
| 39281373 | Outcomes of liver transplantation for hepatocelluler carcinoma from living donor versus deceased donor within University of Southern California San Francisco criteria: a report from Turkey. | Front Oncol | 2024 | https://conductscience.org/library/papers/39281373 | PubMed |
| 39183736 | Living Donor Liver Transplantation for Hepatocellular Carcinoma. | J Clin Exp Hepatol | 2024 | https://conductscience.org/library/papers/39183736 | PubMed |
| 39037684 | Survival benefit of living donor liver transplant for patients with hepatocellular carcinoma. | Updates Surg | 2025 | https://conductscience.org/library/papers/39037684 | PubMed |
| 38704462 | Current role and perspectives of living donor liver transplantation for hepatocellular carcinoma: systematic review of the past 20 years. | Updates Surg | 2025 | https://conductscience.org/library/papers/38704462 | PubMed |
| 38439530 | No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Living Donor Liver Transplantation. | Ann Transplant | 2024 | https://conductscience.org/library/papers/38439530 | PubMed |
| 38304238 | Transplant oncology - Current indications and strategies to advance the field. | JHEP Rep | 2024 | https://conductscience.org/library/papers/38304238 | PubMed |
| 37909200 | Evaluation of Overall Survival and Disease-Free Survival in Patients Receiving Liver Transplantation for Hepatocellular Carcinoma and Comparison of Living Versus Deceased Donor Liver Transplants: Results of 15 Years of Experience. | Eurasian J Med | 2023 | https://conductscience.org/library/papers/37909200 | PubMed |
| 37512101 | Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/37512101 | PubMed |
| 37047199 | Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047199 | PubMed |
| 36672457 | Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36672457 | PubMed |
| 36564609 | Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis. | Hepatol Int | 2023 | https://conductscience.org/library/papers/36564609 | PubMed |
| 35406589 | Automatically Extracted Machine Learning Features from Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT). | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406589 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17511683
GET https://conductscience.org/api/papers/v1/17511683/cited_by?page=2